Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Deutsche Medizinische Wochenschrift (1946)|August 4, 2009
[Information on medications - How do chronically ill patients assess counselling on drugs in general practice?]Cornelia Mahler, S Jank, K Hermann, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1991
Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothoraxR A Schoenenberger, W E Haefeli, P Weiss, et al.
The American Journal of Medicine|February 1, 1993
Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdoseW E Haefeli, R A Schoenenberger, P Weiss, et al.
The American Journal of Physiology|September 2, 1998
Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivoL V Schuerch, L M Linder, E Grouzmann, et al.
Methods of Information in Medicine|November 9, 2010
Design and evaluation of an ontology-based drug application databaseC Senger, H M Seidling, R Quinzler, et al.
Deutsche Medizinische Wochenschrift (1946)|May 5, 2006
[Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model]T Bertsche, M Haas, H Oberwittler, et al.
Schweizerische Medizinische Wochenschrift|July 17, 1999
[Tablets in stool? A common problem!]L V Schuerch, J Nyfeler, G Holder, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Neuropeptide Y in human hand veins: pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivoP Peduzzi, D Simper, L Linder, et al.
The American Journal of Cardiology|May 1, 1991
Concentration-effect relations of 5-hydroxypropafenone in normal subjectsW E Haefeli, S Vozeh, H R Ha, et al.
Epilepsia|November 3, 1998
Quantifying the costs of serious adverse drug reactions to antiepileptic drugsR G Schlienger, P I Oh, S R Knowles, et al.
Pageof 14